⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL9840221 | 0.98 | — | — | |
| SCHEMBL19724585 | 0.66 | LPO (0.30) | — | |
| SCHEMBL18932503 | 0.65 | — | — | |
| SCHEMBL1160445 | 0.64 | — | — | |
| SCHEMBL2015423 | 0.64 | — | — | |
| SCHEMBL2400038 | 0.63 | NOTUM (0.31) | — | |
| SCHEMBL10378076 | 0.62 | — | — | |
| SCHEMBL16116446 | 0.62 | — | — | |
| SCHEMBL9738985 | 0.61 | — | — | |
| SCHEMBL919821 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108137609-A | The cyclic compound of conditioning agent as TNF α | 百时美施贵宝公司 | 2018-06-08 | — | — | CN | claimed |
| CN-107849012-A | A kind of kinase inhibitor | 重庆复创医药研究有限公司 | 2018-03-27 | — | — | CN | claimed |
| EP-3288939-A1 | TRICYCLIC MODULATORS OF TNF SIGNALING | AbbVie Inc. (US) | 2018-03-07 | — | — | EP | claimed |
| WO-2016168641-A1 | TRICYCLIC MODULATORS OF TNF SIGNALING | ABBVIE INC. (US) | 2016-10-20 | — | — | WO | claimed |
| CN-101687865-A | A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | SANOFI AVENTIS | 2010-03-31 | — | — | CN | claimed |
| US-7288123-B2 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-30 | — | — | US | claimed |
| US-20070220685-A1 | Cationic azacyanine dyes and coloring agents containing said dyes | THE PROCTER & GAMBLE COMPANY (US) | 2007-09-27 | — | — | US | claimed |
| CN-101043918-A | Cationic azacyanine dyes and colorants containing said dyes | PROCTER & GAMBLE (US) | 2007-09-26 | — | — | CN | claimed |
| EP-1802375-A1 | CATIONIC AZACYANINE DYES AND COLORANTS CONTAINING THESE | Wella Aktiengesellschaft (DE) | 2007-07-04 | — | — | EP | claimed |
| WO-2007071686-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | claimed |
| EP-1781237-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | The Procter and Gamble Company (US) | 2007-05-09 | — | — | EP | claimed |
| WO-2006042614-A1 | CATIONIC AZACYANINE DYES AND COLORANTS CONTAINING THESE | THE PROCTER & GAMBLE COMPANY (US) | 2006-04-27 | — | — | WO | claimed |
| WO-2006026432-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060042024-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | NOXELL CORPORATION | 2006-03-02 | — | — | US | claimed |
| US-20040231067-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses | L'OREAL (FR) | 2004-11-25 | — | — | US | claimed |
| EP-1428510-A1 | Dyeing composition comprising a tertiary paraphenylenediamine containing a pyrrolidine, and a heterocyclic coupler or a hydroxybenzamide ; method and use | L'OREAL (FR) | 2004-06-16 | — | — | EP | claimed |
| EP-0889718-B1 | KERATIN FIBRE DYE COMPOSITIONS CONTAINING PYRROLO-AZOLE COMPOUNDS, USE THEREOF AS COUPLERS, AND DYEING METHOD | OREAL (FR) | 2002-09-18 | — | — | EP | claimed |
| US-20010020309-A1 | Compositions for dyeing keratinous fibres, containing pyrrolo-azoles; use as couplers; method of dyeing | L'OREAL S.A. | 2001-09-13 | — | — | US | claimed |
| US-6238440-B1 | OXIDATION-DYEING HAIR | L'OREAL S.A. (FR) | 2001-05-29 | — | — | US | claimed |
| US-20260142380-A1 | LIQUID CRYSTAL COMPOSITION FOR RADIO WAVE CONTROL ELEMENT, AND RADIO WAVE CONTROL ELEMENT | FUJIFILM CORPORATION (JP) | 2026-05-21 | — | — | US | disclosed |
| EP-4717691-A1 | USE OF BMPR1B INHIBITOR IN INDUCED DEVELOPMENT, AND INDUCTION CULTURE MEDIUM | Iregene Therapeutics Co., Ltd (CN) | 2026-04-01 | — | — | EP | disclosed |
| EP-4679986-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, PRODUCTION METHOD FOR IMAGING ELEMENT, COMPOUND | FUJIFILM Corporation (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250374741-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORP (JP) | 2025-12-04 | — | — | US | disclosed |
| US-12479859-B2 | Photoelectric conversion element, imaging element, optical sensor, and compound | FUJIFILM CORPORATION (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20250351722-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORP (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250344603-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, METHOD FOR MANUFACTURING IMAGING ELEMENT, AND COMPOUND | FUJIFILM CORP (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4633333-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING DEVICE, PHOTOSENSOR, METHOD FOR PRODUCING IMAGING DEVICE, AND COMPOUND | FUJIFILM Corporation (JP) | 2025-10-15 | — | — | EP | disclosed |
| US-20250294950-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, MANUFACTURING METHOD OF IMAGING ELEMENT, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2025-09-18 | — | — | US | disclosed |
| US-20250215017-A1 | TGF-ß INHIBITOR COMPOUND AND USE THEROF | MEDINNO PHARMACEUTICAL TECHNOLOGY (ZHUHAI) CO., LTD. (CN) | 2025-07-03 | — | — | US | disclosed |
| US-20250212684-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, COMPOUND, AND MANUFACTURING METHOD OF COMPOUND | FUJIFILM CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-4556477-A1 | TGF-BETA INHIBITOR COMPOUND AND USE THEREOF | Medinno Pharmaceutical Technology (Zhuhai) Co., Ltd. (CN) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025070297-A1 | RADIO WAVE CONTROL ELEMENT | 富士フイルム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025069836-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, PRODUCTION METHOD FOR IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025063074-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, METHOD FOR PRODUCING IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2025-03-27 | — | — | WO | disclosed |
| WO-2025063094-A1 | RADIO WAVE CONTROL ELEMENT | 富士フイルム株式会社 | 2025-03-27 | — | — | WO | disclosed |
| WO-2025063058-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, PRODUCTION METHOD FOR IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2025-03-27 | — | — | WO | disclosed |
| WO-2025052923-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, IMAGING ELEMENT PRODUCTION METHOD, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2025-03-13 | — | — | WO | disclosed |
| WO-2025041541-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, PRODUCTION METHOD FOR IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2025-02-27 | — | — | WO | disclosed |
| WO-2025041538-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, PRODUCTION METHOD FOR IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2025-02-27 | — | — | WO | disclosed |
| US-20250063946-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2025-02-20 | — | — | US | disclosed |
| EP-4269416-B1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORP (JP) | 2025-02-19 | — | — | EP | disclosed |
| WO-2025033197-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, METHOD FOR MANUFACTURING IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2025-02-13 | — | — | WO | disclosed |
| WO-2025028340-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, IMAGING ELEMENT PRODUCTION METHOD, AND COMPOUND | 富士フイルム株式会社 | 2025-02-06 | — | — | WO | disclosed |
| US-20250024752-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATON (JP) | 2025-01-16 | — | — | US | disclosed |
| US-20250017107-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| WO-2024262179-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, METHOD FOR PRODUCING IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2024-12-26 | — | — | WO | disclosed |
| WO-2024262486-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, IMAGING ELEMENT PRODUCTION METHOD, AND COMPOUND | 富士フイルム株式会社 | 2024-12-26 | — | — | WO | disclosed |
| WO-2024262173-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, IMAGING ELEMENT PRODUCTION METHOD, AND COMPOUND | 富士フイルム株式会社 | 2024-12-26 | — | — | WO | disclosed |
| WO-2024262437-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, METHOD FOR PRODUCING IMAGING ELEMENT, AND COMPOUND | 富士フイルム株式会社 | 2024-12-26 | — | — | WO | disclosed |
| WO-2024242035-A1 | LIQUID CRYSTAL COMPOSITION FOR RADIO WAVE CONTROL ELEMENT, AND RADIO WAVE CONTROL ELEMENT | 富士フイルム株式会社 | 2024-11-28 | — | — | WO | disclosed |
| US-20240397815-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2024-11-28 | — | — | US | disclosed |
| WO-2024224979-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024202762-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-10-03 | — | — | WO | disclosed |
| WO-2024203704-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-10-03 | — | — | WO | disclosed |
| WO-2024185467-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185810-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185418-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185812-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185744-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, PRODUCTION METHOD FOR IMAGING ELEMENT, COMPOUND | 富士フイルム株式会社 | 2024-09-12 | — | — | WO | disclosed |
| US-20240260458-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2024-08-01 | — | — | US | disclosed |
| US-20240260465-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2024-08-01 | — | — | US | disclosed |
| WO-2024135443-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024122301-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING DEVICE, PHOTOSENSOR, METHOD FOR PRODUCING IMAGING DEVICE, AND COMPOUND | 富士フイルム株式会社 | 2024-06-13 | — | — | WO | disclosed |
| WO-2024099435-A1 | TEAD INHIBITOR | 武汉人福创新药物研发中心有限公司 | 2024-05-16 | — | — | WO | disclosed |
| WO-2024071188-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2024071143-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, COMPOUND, AND COMPOUND PRODUCTION METHOD | 富士フイルム株式会社 | 2024-04-04 | — | — | WO | disclosed |
| WO-2024062871-A1 | PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2024-03-28 | — | — | WO | disclosed |
| WO-2024032589-A1 | TGF-β INHIBITOR COMPOUND AND USE THEREOF | 河南迈英诺医药科技有限公司 | 2024-02-15 | — | — | WO | disclosed |
| EP-3652178-B1 | BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF | HOFFMANN LA ROCHE (CH) | 2024-01-24 | — | — | EP | disclosed |
| EP-4290596-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | FUJIFILM Corporation (JP) | 2023-12-13 | — | — | EP | disclosed |
| US-20230380275-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFLM CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| WO-2023219033-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-11-16 | — | — | WO | disclosed |
| WO-2023218933-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-11-16 | — | — | WO | disclosed |
| WO-2023219042-A1 | PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-11-16 | — | — | WO | disclosed |
| WO-2023210772-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-11-02 | — | — | WO | disclosed |
| EP-4269416-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM Corporation (JP) | 2023-11-01 | — | — | EP | disclosed |
| US-20230345826-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| CN-116889118-A | Photoelectric conversion element, imaging element, photosensor, and compound | 富士胶片株式会社 | 2023-10-13 | — | — | CN | disclosed |
| WO-2023189605-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190224-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-20230301121-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| EP-4244224-A1 | SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE | JANSSEN Pharmaceutica NV (BE) | 2023-09-20 | — | — | EP | disclosed |
| WO-2023171788-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-09-14 | — | — | WO | disclosed |
| CN-116615081-A | Photoelectric conversion element, imaging element, photosensor, and compound | 富士胶片株式会社 | 2023-08-18 | — | — | CN | disclosed |
| CN-116601156-A | Photoelectric conversion element, imaging element, photosensor, and compound | 富士胶片株式会社 | 2023-08-15 | — | — | CN | disclosed |
| WO-2023054346-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-04-06 | — | — | WO | disclosed |
| WO-2023038064-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2023-03-16 | — | — | WO | disclosed |
| WO-2023280254-A1 | TEAD INHIBITOR | 武汉人福创新药物研发中心有限公司 | 2023-01-12 | — | — | WO | disclosed |
| WO-2022249972-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2022-12-01 | — | — | WO | disclosed |
| WO-2022168856-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, PHOTOSENSOR, AND COMPOUND | 富士フイルム株式会社 | 2022-08-11 | — | — | WO | disclosed |
| WO-2022138833-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | 富士フイルム株式会社 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022104348-A1 | SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE | JANSSEN PHARMACEUTICA NV (BE) | 2022-05-19 | — | — | WO | disclosed |
| CN-110506039-A | Compounds and methods for targeted degradation of androgen receptor | ARVINAS INC | 2019-11-26 | — | — | CN | disclosed |
| CN-107108672-B | Condensed five rings imdazole derivatives | UCB生物制药私人有限公司 | 2019-11-08 | — | — | CN | disclosed |
| CN-109970708-A | Cannibinoid receptor modulators | 艾尼纳制药公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-103492369-B | Cannabinoid receptor modulators | 艾尼纳制药公司 | 2019-03-29 | — | — | CN | disclosed |
| WO-2019035008-A1 | CDK4/6 INHIBITORS AND USE THEREOF | BEIJING XUANYI PHARMASCIENCES CO., LTD. (CN) | 2019-02-21 | — | — | WO | disclosed |
| CN-108883308-A | Compositions and uses of alpha-adrenergic agents | 利维申制药有限公司 | 2018-11-23 | — | — | CN | disclosed |
| CN-108602802-A | Aminopyrimidines useful for inhibiting protein tyrosine kinase activity | 深圳市塔吉瑞生物医药有限公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-108137609-A | The cyclic compound of conditioning agent as TNF α | 百时美施贵宝公司 | 2018-06-08 | — | — | CN | disclosed |
| US-9963452-B2 | Methods, compounds, and compositions for inhibition of ROS | AUGUSTA PHARMACEUTICALS INC. (US) | 2018-05-08 | — | — | US | disclosed |
| CN-105814048-B | Fused tricyclic benzimidizole derivatives as TNF active regulators | UCB生物制药私人有限公司 | 2018-03-27 | — | — | CN | disclosed |
| CN-107849012-A | A kind of kinase inhibitor | 重庆复创医药研究有限公司 | 2018-03-27 | — | — | CN | disclosed |
| EP-3288939-A1 | TRICYCLIC MODULATORS OF TNF SIGNALING | AbbVie Inc. (US) | 2018-03-07 | — | — | EP | disclosed |
| CN-104718213-B | 5, 5-heteroaromatic anti-infective compounds | 圣母大学 | 2018-02-27 | — | — | CN | disclosed |
| US-20180050997-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2018-02-22 | — | — | US | disclosed |
| US-20170368039-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | FORMA TM, LLC (US) | 2017-12-28 | — | — | US | disclosed |
| EP-2182914-B1 | COMPOSITION OXIDATION COLOURING OF KERATINIC FIBRES, CONTAINING A CATIONIC CELLULOSE ETHER, A METASILICATE AND OXIDATION DYES, METHOD FOR OXIDATION COLOURING AND USES THEREOF | L'ORÉAL (FR) | 2017-11-08 | — | — | EP | disclosed |
| US-20170312273-A1 | METHODS OF USING FASN INHIBITORS | FORMA THERAPEUTICS, INC. | 2017-11-02 | — | — | US | disclosed |
| CN-107108672-A | The five rings imdazole derivatives of fusion | UCB生物制药私人有限公司 | 2017-08-29 | — | — | CN | disclosed |
| US-9676721-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2017-06-13 | — | — | US | disclosed |
| CN-104220488-B | New diamine, polymer, aligning agent for liquid crystal, liquid crystal orientation film and use its liquid crystal display cells | 日产化学工业株式会社 | 2017-05-31 | — | — | CN | disclosed |
| US-20170137441-A1 | Piperidine Derivatives And Compositions For the Inhibition Of Nicotinamide Phosphoribosyltransferase (NAMPT) | VALO EARLY DISCOVERY, INC. | 2017-05-18 | — | — | US | disclosed |
| CN-106608879-A | Protein kinase inhibitor and its preparation method and medical application | 甘李药业股份有限公司 | 2017-05-03 | — | — | CN | disclosed |
| US-9555039-B2 | Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT) | FORMA TM, LLC. (US) | 2017-01-31 | — | — | US | disclosed |
| WO-2016168641-A1 | TRICYCLIC MODULATORS OF TNF SIGNALING | ABBVIE INC. (US) | 2016-10-20 | — | — | WO | disclosed |
| US-20160229866-A1 | HEPATITIS C VIRUS INHIBITORS | IDENIX PHARMACEUTICALS INC. (US) | 2016-08-11 | — | — | US | disclosed |
| US-20160031890-A1 | NOVEL METHODS, COMPOUNDS, AND COMPOSITIONS FOR INHIBITION OF ROS | GRUENEBERG, Dorre A. | 2016-02-04 | — | — | US | disclosed |
| US-20160002188-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | FORMA THERAPEUTICS, INC. | 2016-01-07 | — | — | US | disclosed |
| US-9187496-B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | IDENIX PHARMACEUTICALS LLC (US) | 2015-11-17 | — | — | US | disclosed |
| US-9169209-B2 | Compounds and compositions for the inhibition of NAMPT | FORMA TM, LLC (US) | 2015-10-27 | — | — | US | disclosed |
| EP-2175830-B1 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | ORÉAL L (FR) | 2015-09-30 | — | — | EP | disclosed |
| EP-2773631-B1 | PESTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2015-09-09 | — | — | EP | disclosed |
| US-20150232424-A1 | PESTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2015-08-20 | — | — | US | disclosed |
| CN-104725601-A | Easily processed dianhydride hardener for epoxy resin systems based on 5,5 '-dicarbonyl (isobenzofuran-1,3-dion) | EVONIK INDUSTRIES AG | 2015-06-24 | — | — | CN | disclosed |
| CN-104725602-A | Easily processed dianhydride hardener for epoxy resin systems based on 5,5 '-oxybis (isobenzofuran-1,3-dion) | EVONIK INDUSTRIES AG | 2015-06-24 | — | — | CN | disclosed |
| US-8987465-B2 | Pesticidal compounds | SYNGENTA PARTICIPATION AG (CH) | 2015-03-24 | — | — | US | disclosed |
| US-20140296066-A1 | PESTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2014-10-02 | — | — | US | disclosed |
| US-20140275057-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | Valo Health, LLC | 2014-09-18 | — | — | US | disclosed |
| EP-2773631-A1 | PESTICIDAL COMPOUNDS | Syngenta Participations AG (CH) | 2014-09-10 | — | — | EP | disclosed |
| US-20140248240-A1 | PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) | VALO HEALTH, INC. | 2014-09-04 | — | — | US | disclosed |
| CN-103561736-A | Methods for treating drug-resistant hepatitis C virus infection with a 5,5-fused arylene or heteroarylene hepatitis C virus inhibitor | IDENIX PHARMACEUTICALS INC | 2014-02-05 | — | — | CN | disclosed |
| CN-103524715-A | Hardener for epoxy resin systems and their applications | EVONIK INDUSTRIES AG | 2014-01-22 | — | — | CN | disclosed |
| US-20130295051-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO HEALTH, INC. | 2013-11-07 | — | — | US | disclosed |
| US-20130273034-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT | VALO EARLY DISCOVERY, INC. | 2013-10-17 | — | — | US | disclosed |
| WO-2013064519-A1 | PESTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2013-05-10 | — | — | WO | disclosed |
| US-20130071352-A1 | 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-8362068-B2 | 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors | IDENIX PHARMACEUTICALS, INC. (US) | 2013-01-29 | — | — | US | disclosed |
| CN-102822175-A | 5, 5-fused arylene or heteroarylene hepatitis C virus inhibitors | IDENIX PHARMACEUTICALS INC (US) | 2012-12-12 | — | — | CN | disclosed |
| US-20120252721-A1 | METHODS FOR TREATING DRUG-RESISTANT HEPATITIS C VIRUS INFECTION WITH A 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITOR | IDENIX PHARMACEUTICALS, INC. (US) | 2012-10-04 | — | — | US | disclosed |
| US-8043385-B2 | Composition oxidation colouring of keratinic fibres, containing a cationic cellulose ether, a metasilicate and oxidation dyes, method for oxidation colouring and uses thereof | L'OREAL S.A. (FR) | 2011-10-25 | — | — | US | disclosed |
| US-8002847-B2 | Composition for oxidation dyeing keratin fibres comprising a cationic cellulose ether, a weakly oxyethylenated sorbitan fatty acid ester and oxidation dyes | L 'OREAL S.A. (FR) | 2011-08-23 | — | — | US | disclosed |
| CN-102124008-A | Novel pyrroloindole derivatives as Hsp90 inhibitors, compositions containing said derivatives and uses thereof | SANOFI AVENTIS | 2011-07-13 | — | — | CN | disclosed |
| US-20110150827-A1 | 5,5-FUSED ARYLENE OR HETEROARYLENE HEPATITIS C VIRUS INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20100275388-A1 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | L'OREAL S.A. (FR) | 2010-11-04 | — | — | US | disclosed |
| US-20100263138-A1 | COMPOSITION OXIDATION COLOURING OF KERATINIC FIBRES, CONTAINING A CATIONIC CELLULOSE ETHER, A METASILICATE AND OXIDATION DYES, METHOD FOR OXIDATION COLOURING AND USES THEREOF | L'OREAL S.A. (FR) | 2010-10-21 | — | — | US | disclosed |
| CN-101043918-B | Cationic azacyanine dyes and colorants containing said dyes | PROCTER & GAMBLE | 2010-05-26 | — | — | CN | disclosed |
| EP-2182914-A2 | COMPOSITION OXIDATION COLOURING OF KERATINIC FIBRES, CONTAINING A CATIONIC CELLULOSE ETHER, A METASILICATE AND OXIDATION DYES, METHOD FOR OXIDATION COLOURING AND USES THEREOF | L'Oreal (FR) | 2010-05-12 | — | — | EP | disclosed |
| US-20100099730-A1 | ANNELLATED PYRROLE COMPOUNDS FOR CANCER MANAGEMENT | MERCKLE GMBH (DE) | 2010-04-22 | — | — | US | disclosed |
| EP-2175830-A2 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | L'Oreal (FR) | 2010-04-21 | — | — | EP | disclosed |
| CN-101687865-A | A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles | SANOFI AVENTIS | 2010-03-31 | — | — | CN | disclosed |
| US-7608717-B2 | Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands | WYETH (US) | 2009-10-27 | — | — | US | disclosed |
| EP-2046326-A2 | ANNELLATED PYRROLE COMPOUNDS FOR CANCER MANAGEMENT | MERCKLE GMBH (DE) | 2009-04-15 | — | — | EP | disclosed |
| WO-2009019383-A2 | COMPOSITION OXIDATION COLOURING OF KERATINIC FIBRES, CONTAINING A CATIONIC CELLULOSE ETHER, A METASILICATE AND OXIDATION DYES, METHOD FOR OXIDATION COLOURING AND USES THEREOF | L'OREAL (FR) | 2009-02-12 | — | — | WO | disclosed |
| WO-2009016061-A2 | COMPOSITION FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC CELLULOSE ETHER, A WEAKLY OXYETHYLENATED SORBITAN FATTY ACID ESTER AND OXIDATION DYES | L'OREAL (FR) | 2009-02-05 | — | — | WO | disclosed |
| US-7425573-B2 | Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration | MERCKLE GMBH (DE) | 2008-09-16 | — | — | US | disclosed |
| US-7374583-B2 | Cationic azacyanine dyes and coloring agents containing said dyes | THE PROCTER & GAMBLE COMPANY (US) | 2008-05-20 | — | — | US | disclosed |
| US-20080070943-A1 | Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands | WYETH (US) | 2008-03-20 | — | — | US | disclosed |
| EP-1884239-A1 | Annellated pyrrole compounds for cancer management | MERCKLE GMBH (DE) | 2008-02-06 | — | — | EP | disclosed |
| WO-2008012110-A2 | ANNELLATED PYRROLE COMPOUNDS FOR CANCER MANAGEMENT | MERCKLE GMBH (DE) | 2008-01-31 | — | — | WO | disclosed |
| US-7291736-B2 | Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands | WYETH (US) | 2007-11-06 | — | — | US | disclosed |
| US-7288123-B2 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | THE PROCTER & GAMBLE COMPANY (US) | 2007-10-30 | — | — | US | disclosed |
| US-20070220685-A1 | Cationic azacyanine dyes and coloring agents containing said dyes | THE PROCTER & GAMBLE COMPANY (US) | 2007-09-27 | — | — | US | disclosed |
| CN-101043918-A | Cationic azacyanine dyes and colorants containing said dyes | PROCTER & GAMBLE (US) | 2007-09-26 | — | — | CN | disclosed |
| CN-101010060-A | Keratin dyeing compounds, keratin dyeing compositions containing them and their use | PROCTER & GAMBLE (US) | 2007-08-01 | — | — | CN | disclosed |
| EP-1802375-A1 | CATIONIC AZACYANINE DYES AND COLORANTS CONTAINING THESE | Wella Aktiengesellschaft (DE) | 2007-07-04 | — | — | EP | disclosed |
| WO-2007071686-A1 | COMPOSITION FOR DYEING KERATIN FIBRES WITH A TETRAAZAPENTAMETHINE CATIONIC DIRECT DYE, AN OXIDATION BASE AND A PARTICULAR COUPLER | L'ORÉAL (FR) | 2007-06-28 | — | — | WO | disclosed |
| EP-1781237-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | The Procter and Gamble Company (US) | 2007-05-09 | — | — | EP | disclosed |
| CN-1309383-C | Annelated pyrrole compounds as proton pump inhibitors for treating ulcer | MERCKLE GMBH (DE) | 2007-04-11 | — | — | CN | disclosed |
| US-7132441-B2 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | G.D. SEARLE & CO. (US) | 2006-11-07 | — | — | US | disclosed |
| WO-2006042614-A1 | CATIONIC AZACYANINE DYES AND COLORANTS CONTAINING THESE | THE PROCTER & GAMBLE COMPANY (US) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006026432-A1 | KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2006-03-09 | — | — | WO | disclosed |
| US-20060042024-A1 | Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof | NOXELL CORPORATION | 2006-03-02 | — | — | US | disclosed |
| US-20060040945-A1 | Annellated pyrrole compounds as proton pump inhibitors for treating ulcer | MERCKLE GMBH (DE) | 2006-02-23 | — | — | US | disclosed |
| US-6936632-B2 | Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof | MERCKLE GMBH (DE) | 2005-08-30 | — | — | US | disclosed |
| CN-1652771-A | Annelated pyrrole compounds as proton pump inhibitors for treating ulcer | MERCKLE GMBH (DE) | 2005-08-10 | — | — | CN | disclosed |
| CN-1191254-C | Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof | MARCKLE GMBH (DE) | 2005-03-02 | — | — | CN | disclosed |
| EP-1505964-A1 | ANNELATED PYRROLE COMPOUNDS AS PROTON PUMP INHIBITORS FOR TREATING ULCER | MERCKLE GMBH (DE) | 2005-02-16 | — | — | EP | disclosed |
| US-20050004108-A1 | Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degenaration | MERCKLE GMBH (DE) | 2005-01-06 | — | — | US | disclosed |
| US-20040231067-A1 | Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses | L'OREAL (FR) | 2004-11-25 | — | — | US | disclosed |
| CN-1549711-A | Use of fused pyrrole compounds for the treatment of articular cartilage or subchondral bone degeneration | ��Ĭ���� | 2004-11-24 | — | — | CN | disclosed |
| US-20040122002-A1 | Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof | MERCKLE GMBH (DE) | 2004-06-24 | — | — | US | disclosed |
| EP-1427410-A1 | USE OF ANNELLATED PYRROLE COMPOUNDS IN THE TREATMENT OF ARTICULAR CARTILAGE OR SUBCHONDRAL BONE DEGENERATION | MERCKLE GMBH (DE) | 2004-06-16 | — | — | EP | disclosed |
| EP-1428510-A1 | Dyeing composition comprising a tertiary paraphenylenediamine containing a pyrrolidine, and a heterocyclic coupler or a hydroxybenzamide ; method and use | L'OREAL (FR) | 2004-06-16 | — | — | EP | disclosed |
| EP-1246825-B1 | FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF | MERCKLE GMBH (DE) | 2003-12-17 | — | — | EP | disclosed |
| WO-2003097041-A1 | ANNELATED PYRROLE COMPOUNDS AS PROTON PUMP INHIBITORS FOR TREATING ULCER | MERCKLE GMBH (DE) | 2003-11-27 | — | — | WO | disclosed |
| CN-1418217-A | Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof | MARCKLE GMBH (DE) | 2003-05-14 | — | — | CN | disclosed |
| WO-2003020267-A1 | USE OF ANNELLATED PYRROLE COMPOUNDS IN THE TREATMENT OF ARTICULAR CARTILAGE OR SUBCHONDRAL BONE DEGENERATION | MERCKLE GMBH (DE) | 2003-03-13 | — | — | WO | disclosed |
| CN-1382044-A | Use of cell factor inhibiting anti-inflammatory agent in rhinovirus infection | SMITHKLINE BEECHAM CORP (US) | 2002-11-27 | — | — | CN | disclosed |
| US-6476175-B2 | REACTING LACTONE WITH DIAMINE BY HEATING; POLYURETHANE POLYMERIZATION CATALYST | LONZA LTD. (CH) | 2002-11-05 | — | — | US | disclosed |
| EP-1246825-A1 | FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF | MERCKLE GMBH (DE) | 2002-10-09 | — | — | EP | disclosed |
| EP-0889718-B1 | KERATIN FIBRE DYE COMPOSITIONS CONTAINING PYRROLO-AZOLE COMPOUNDS, USE THEREOF AS COUPLERS, AND DYEING METHOD | OREAL (FR) | 2002-09-18 | — | — | EP | disclosed |
| EP-0662476-B2 | Process for the preparation of bicyclic amidines | LONZA AG (CH) | 2002-08-14 | — | — | EP | disclosed |
| US-6376528-B1 | SYNERGISTIC MIXTURE | G. D. SEARLE & CO. | 2002-04-23 | — | — | US | disclosed |
| US-20020028939-A1 | Bicyclic amidines, process for their preparation, and their use as catalyst | WERBITZKY OLEG (CH) | 2002-03-07 | — | — | US | disclosed |
| US-6342510-B1 | ANTIINFLAMMATORY AGENTS AND ENZYME INHIBITORS | G. D. SEARLE & CO. | 2002-01-29 | — | — | US | disclosed |
| US-20010020309-A1 | Compositions for dyeing keratinous fibres, containing pyrrolo-azoles; use as couplers; method of dyeing | L'OREAL S.A. | 2001-09-13 | — | — | US | disclosed |
| WO-2001051491-A1 | FUSED PYRROLE COMPOUNDS, PHARMACEUTICAL AGENTS CONTAINING THE SAME, AND THE USE THEREOF | MERCKLE GMBH (DE) | 2001-07-19 | — | — | WO | disclosed |
| US-6255488-B1 | BICYCLIC AMIDINES HAVING AMINO, HYDROXYL, AND/OR MERCAPTO GROUPS USEFUL AS CATALYSTS FOR PREPARATION OF POLYURETHANES; WHICH BOND FIRMLY TO THE POLYMER WITH NO TENDENCY TOWARDS MIGRATION | LONZA AG (CH) | 2001-07-03 | — | — | US | disclosed |
| US-6238440-B1 | OXIDATION-DYEING HAIR | L'OREAL S.A. (FR) | 2001-05-29 | — | — | US | disclosed |
| EP-0306300-B1 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORP (US) | 1995-05-03 | — | — | EP | disclosed |
| US-5145858-A | Antiinflammatory | SMITHKLINE BEECHAM CORP. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5145858-A | Antiinflammatory | SMITHKLINE BEECHAM CORP. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5002941-A | Antiarthritic agents, arachidonic acid metabolism | SMITHKLINE BEECHAM CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| US-5002941-A | Antiarthritic agents, arachidonic acid metabolism | SMITHKLINE BEECHAM CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| US-5002941-A | Antiarthritic agents, arachidonic acid metabolism | SMITHKLINE BEECHAM CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| WO-1991000092-A1 | INHIBITION OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR PRODUCTION BY MONOCYTES AND/OR MACROPHAGES | SMITHKLINE BEECHAM CORPORATION (US) | 1991-01-10 | — | — | WO | disclosed |
| EP-0403251-A2 | Monokine activity interference | SMITHKLINE BEECHAM CORPORATION (US) | 1990-12-19 | — | — | EP | disclosed |
| EP-0150255-B1 | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine immunomodulators | FISONS CORPORATION (US) | 1990-12-12 | — | — | EP | disclosed |
| WO-1990003789-A1 | PYRROLO[1,2-a]IMIDAZOLE AND IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR USE AS 5-LYPOXYGENASE PATHWAY INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-19 | — | — | WO | disclosed |
| WO-1990003789-A1 | PYRROLO[1,2-a]IMIDAZOLE AND IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR USE AS 5-LYPOXYGENASE PATHWAY INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-19 | — | — | WO | disclosed |
| EP-0364204-A1 | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-18 | — | — | EP | disclosed |
| EP-0364204-A1 | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-18 | — | — | EP | disclosed |
| CN-1032011-A | Pyrrolo-imidazoles and imidazopyridine and application thereof | SMITHKLINE BECKMAN CORP (US) | 1989-03-29 | — | — | CN | disclosed |
| EP-0306300-A2 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1989-03-08 | — | — | EP | disclosed |
| EP-0306300-A2 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1989-03-08 | — | — | EP | disclosed |
| US-4719218-A | ENZYME INHIBITORS | SMITHKLINE BECKMAN CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| CN-86108538-A | The inhibition of 5-lipoxygenase pathway | — | 1987-07-29 | — | — | CN | disclosed |
| US-4603206-A | ALCOHOLS, ETHERS FROM MERCAPTANS, SULFIDES;POSITIVE HALOGENATING AGENT; ALCOHOL; IMMUNOMODULATORS | PENNWALT CORPORATION (US) | 1986-07-29 | — | — | US | disclosed |
| US-4560758-A | IMMUNOMODULATORS | PENNWALT CORPORATION (US) | 1985-12-24 | — | — | US | disclosed |
| EP-0150255-A2 | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine immunomodulators | FISONS CORPORATION (US) | 1985-08-07 | — | — | EP | disclosed |
| US-4507481-A | IMMUNOMODULATORS | PENNWALT CORPORATION (US) | 1985-03-26 | — | — | US | disclosed |
| US-4186205-A | ANTIARTHRITIC AGENTS | SMITHKLINE CORPORATION (US) | 1980-01-29 | — | — | US | disclosed |
| US-4126685-A | 6-Aryl-pyrrolo[1,2,9]imidazole derivatives which possess anti-hypertensive activity | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-11-21 | — | — | US | disclosed |
| US-4126685-A | 6-Aryl-pyrrolo[1,2,9]imidazole derivatives which possess anti-hypertensive activity | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-11-21 | — | — | US | disclosed |